Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. .I Koukourakis et al., Laboratory Investigation, 2017, 97: 1321-1331, doi:10.1038/labinvest.2017.79 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. L. Rulten et al., Nucleic Acids Res., Jan 2014; 42: 307 - 314 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Z. Zeng et al., DNA Repair, October 2017, 58: 52-61 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. V. Karagounis et al., British Journal of Cancer, 2016, 115: 312-321; doi: 10.1038/bjc.2016.202 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H. Brunton et al., Mol. Cell. Biol., Oct 2011; 31: 4022 - 4035 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P.-S. Hsu et al., Int. J. Mol. Sci., 2015, 16: 27640-27658; doi:10.3390/ijms161126045 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M.-J. Kim et al., Cancer Letters, 2013, 339: 15–24, doi.org/10.1016/j.canlet.2013.07.027 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | I-T. Lee et al., J. of Nutritional Biochemistry, 2013, 24: 124–136, doi.org/10.1016/j.jnutbio.2012.03.009 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | W. Kim et al., J. Biol. Chem., 287 (8): 5278–5289, DOI 10.1074/jbc.M111.281709 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin et al., Am J Physiol Lung Cell Mol Physiol, Sep 2012; 303: L401 - L412 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | P. Hubel et al., Nature Immunology, 2019, 20: 493–502, https://doi.org/10.1038/s41590-019-0323-3. | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Tsolou et al., Cancer Biol. Med., 2017, 14 (3): 293-301, doi: 10.20892/j.issn.2095-3941.2017.0049 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., Apr 2010; 19: 1324 - 1334 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S.-E. Cheng et al., PLoS ONE, 2013, 8(1): e54125. doi:10.1371/journal.pone.0054125 | Link | |
hBCSCs |
Human breast cancer stem cells (from xenografts of human breast cancers) | Human | respiratory system | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | W.-W. Chang et al., Breast Cancer Res., 2013, 15: R39, doi:10.1186/bcr3423 | Link | ||
HLF |
Human lung fibroblasts | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | X. Deng et al., J. Cell. Biochem., 2017, 118: 4012-4019, DOI 10.1002/jcb.26057 | |||
hPAEpiC |
Human pulmonary alveolar epithelial cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin, PLoS ONE, 2015, 10(3): e0118473; doi:10.1371/journal.pone.0118473 | Link | ||
HPAEpiC |
Human pulmonary alveolar epithelial cells (type II) | Human | respiratory system | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | I-T. Lee et al., J. of Nutritional Biochemistry, 2013, 24: 124–136, doi.org/10.1016/j.jnutbio.2012.03.009 | |||
HPAEpiC |
Human pulmonary alveolar epithelial cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin et al., Front. Pharmacol. 2016, 7:80; doi: 10.3389/fphar.2016.00080 | Link | ||
hPASMC |
Human pulmonary artery smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | Z. Qian et al., Am. J. Physiol. Cell Physiol., July 2017, 313: C380 -C391; doi:10.1152/ajpcell.00061.2017 | |||
hTSMC |
Human primary tracheal smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-M. Yang et al., Am J Physiol Lung Cell Mol Physiol, Nov 2009; 297: L892 - L902 | Link | ||
hTSMC |
Human primary tracheal smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-W. Lee et al., Mol. Pharmacol., May 2008; 73: 1454 - 1464 |